Replies to post #143755 on Biotech Values

[dewophile]

i think it's a multibillion dollar drug if approved based on the novel MOA and huge need for those in whom gaba-ergic drugs (including benzos and the more specific gaba A drugs) don't work
jmo
PS: i'll be first in line to try it

[DewDiligence]

MRK—so the key now becomes rather it has to have rems program or not. That’s what will determine if its 500 million dollar drug verses 2-3 billion???

The REMS, if there is one, will not make a 6x difference or have anywhere near that kind of effect in the sales potential of suvorexant. Rather, what will determine whether this is a medium-selling drug or a huge-selling drug is how well it actually works in the real world.